TRUALT BIOENERGY LIMITED TRUALT NSEINFRA
Company Overview
TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022. TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.
Why Investors Should Care
Net profit has compounded at 25.5% per year over the last five years.
Revenue has grown at a 14.2% CAGR over the past five years.
Recent Developments
- Mar 2026 Revenue of ₹1,727.51 Cr (-9.4% YoY); net profit ₹96.87 Cr.
- Trailing 12 Months Year-on-year growth — revenue -9.4%, earnings -33.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 14.2%, profit CAGR 25.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 14.18% |
| 1 Year: | -9.45% |
Compounded Profit Growth
| 5 Years: | 25.50% |
| 1 Year: | -33.94% |
Stock Price Performance
| 1 Year: | -16.76% |
| 6 Months: | +15.84% |
| 3 Months: | -20.06% |
| 1 Month: | -8.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.83 · Neutral
P/E of 34.57 is above the sector median of 19.52 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 14.2% over 5 years.
- Profit CAGR of 25.5% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Energy).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TRUALT TRUALT BIOENERGY LIMITED NSEINFRA | 425.25 | 34.57 | ₹3,646.63 Cr | 0.00% | 10.77% | 6.37% | 14.18% | 25.50% |
| 2 | RELIANCE Reliance Industries Limited NIFTY50NSEAIINFRA | 1,322.00 | 22.15 | ₹17.89 L Cr | 0.45% | 8.99% | 8.93% | 6.39% | 6.59% |
| 3 | ADANIENT Adani Enterprises Limited NIFTY50NSEAIINFRA | 2,938.00 | 39.92 | ₹3.80 L Cr | 0.04% | 9.83% | 11.54% | -7.67% | 55.92% |
| 4 | ONGC Oil and Natural Gas Corporation Limited NIFTY50NSEINFRAPSU | 234.65 | 7.13 | ₹2.95 L Cr | 6.10% | 12.57% | 11.14% | -1.30% | 4.11% |
| 5 | COALINDIA Coal India Limited NIFTY50NSEINFRAPSU | 415.35 | 8.23 | ₹2.56 L Cr | 5.05% | 19.79% | 26.11% | 9.74% | -0.71% |
| 6 | IOC Indian Oil Corporation Limited NSEINFRAPSU | 137.60 | 4.50 | ₹1.94 L Cr | 5.78% | 20.53% | 19.18% | -2.21% | 62.60% |
| 7 | BPCL Bharat Petroleum Corporation Limited NIFTY50NSEINFRAPSU | 315.70 | 5.22 | ₹1.37 L Cr | 6.18% | 26.36% | 25.80% | -1.15% | 129.75% |
| 8 | OIL Oil India Limited NIFTY_MIDNSEINFRAPSU | 488.30 | 12.00 | ₹79,427.26 Cr | 4.28% | 10.13% | 11.41% | -2.02% | -8.81% |
| 9 | HINDPETRO Hindustan Petroleum Corporation Limited NIFTY_MIDNSEINFRA | 356.50 | 4.20 | ₹75,856.87 Cr | 6.14% | 23.32% | 27.53% | 0.21% | 119.51% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 197.00 Cr | 388.00 Cr | - | 906.99 Cr | 303.89 Cr | 115.00 Cr | 713.24 Cr | 595.52 Cr | 626.88 Cr |
| Cost of Revenue | - | - | - | 615.19 Cr | 240.44 Cr | - | 515.56 Cr | 331.69 Cr | 416.60 Cr |
| Gross Profit | - | - | - | 291.80 Cr | 63.45 Cr | - | 197.68 Cr | 263.83 Cr | 210.28 Cr |
| Operating Expenses | 184.00 Cr | 371.00 Cr | - | 155.60 Cr | 42.61 Cr | 119.00 Cr | 85.48 Cr | 168.01 Cr | 102.33 Cr |
| Operating Income | -2.00 Cr | 1.00 Cr | - | 136.20 Cr | 20.85 Cr | -26.00 Cr | 112.19 Cr | 95.82 Cr | 107.96 Cr |
| EBITDA | 14.00 Cr | 17.00 Cr | - | 149.89 Cr | 43.59 Cr | -5.00 Cr | 129.82 Cr | 127.20 Cr | 122.48 Cr |
| Interest Expense | 35.00 Cr | 34.00 Cr | - | 38.99 Cr | 37.79 Cr | 39.00 Cr | 40.13 Cr | 43.50 Cr | 44.03 Cr |
| Pretax Income | -22.00 Cr | -16.00 Cr | - | 110.90 Cr | 5.80 Cr | -49.00 Cr | 89.68 Cr | 83.70 Cr | 78.45 Cr |
| Tax Provision | 0 | -2.40 Cr | - | -79.58 L | 1.07 Cr | 11.27 Cr | 20.49 Cr | 22.75 Cr | 19.17 Cr |
| Net Income | -22.00 Cr | -19.00 Cr | - | 111.69 Cr | 4.73 Cr | -38.00 Cr | 69.33 Cr | 60.95 Cr | 57.15 Cr |
| Diluted EPS | -3.05 | -2.64 | - | 13.03 | 0.55 | -4.42 | 8.07 | 6.99 | 6.67 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,160.39 Cr | 1,223.04 Cr | 1,907.72 Cr | 1,727.51 Cr |
| Cost of Revenue | - | 839.30 Cr | 921.10 Cr | 1,338.51 Cr | 1,200.68 Cr |
| Gross Profit | - | 321.09 Cr | 301.93 Cr | 569.21 Cr | 526.82 Cr |
| Operating Expenses | - | 195.82 Cr | 170.77 Cr | 326.96 Cr | 323.30 Cr |
| Operating Income | - | 125.27 Cr | 131.17 Cr | 242.25 Cr | 203.53 Cr |
| EBITDA | - | 153.48 Cr | 237.98 Cr | 369.95 Cr | 376.21 Cr |
| Interest Expense | - | 56.86 Cr | 136.19 Cr | 143.61 Cr | 160.02 Cr |
| Pretax Income | - | 67.09 Cr | 44.87 Cr | 159.44 Cr | 129.95 Cr |
| Tax Provision | - | 18.08 Cr | 13.07 Cr | 12.80 Cr | 33.08 Cr |
| Net Income | - | 49.01 Cr | 31.81 Cr | 146.64 Cr | 96.87 Cr |
| Diluted EPS | - | - | - | - | 12.30 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 1,855.98 Cr | 2,419.08 Cr | 3,029.73 Cr | 3,778.34 Cr |
| Current Assets | - | 464.10 Cr | 658.13 Cr | 1,062.20 Cr | 1,478.75 Cr |
| Cash & Equivalents | - | 4.78 Cr | 23.35 Cr | 149.78 Cr | 88.26 Cr |
| Inventory | - | 153.49 Cr | 159.48 Cr | 210.21 Cr | 528.43 Cr |
| Receivables | - | 86.54 Cr | 298.21 Cr | 339.27 Cr | 406.11 Cr |
| Total Liabilities | - | 1,615.48 Cr | 2,154.47 Cr | 2,260.73 Cr | 2,200.01 Cr |
| Current Liabilities | - | 442.53 Cr | 1,061.48 Cr | 1,047.50 Cr | 1,084.73 Cr |
| Long Term Debt | - | 783.53 Cr | 979.58 Cr | 1,117.15 Cr | 988.68 Cr |
| Total Debt | - | 863.30 Cr | 1,366.55 Cr | 1,556.54 Cr | 1,651.51 Cr |
| Total Equity | - | 240.49 Cr | 264.61 Cr | 769.00 Cr | 1,520.33 Cr |
| Shares Outstanding | - | - | - | - | 8.58 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 51.60 Cr | 35.48 Cr | 342.03 Cr | -295.63 Cr |
| Investing Cash Flow | - | -473.82 Cr | -383.67 Cr | -255.33 Cr | -413.45 Cr |
| Financing Cash Flow | - | 419.98 Cr | 366.76 Cr | 39.72 Cr | 647.56 Cr |
| Capital Expenditure | - | -488.20 Cr | -356.80 Cr | -259.70 Cr | -510.68 Cr |
| Free Cash Flow | - | -436.61 Cr | -321.33 Cr | 82.33 Cr | -806.31 Cr |
| Net Change in Cash | - | -2.25 Cr | 18.57 Cr | 126.43 Cr | -61.52 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 27.7% | 24.7% | 29.8% | 30.5% |
| Operating Margin % | - | 10.8% | 10.7% | 12.7% | 11.8% |
| Net Margin % | - | 4.2% | 2.6% | 7.7% | 5.6% |
| ROE % | - | 20.4% | 12.0% | 19.1% | 6.4% |
| ROCE % | - | 8.9% | 9.7% | 12.2% | 7.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TRUALT
Transcript : TruAlt Bioenergy Limited, Q1 2027 Earnings Call, Jul 29, 2026 - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQbFo3LXZNNGVwNlZmdDUtOU5Vd2xhN250dTh2OXBuR3VpM25VQWhLU0owZmctRVBaV0J3MVZweko0Y2tTcllGblpESm1RV0RKSHl5T21SdV8tSHFwX2Mzcm5wLUM4OTZHdWxUbjhtSzI0T3lyQU40ZVB3WHNwYjBtRUNxVng0RGJFLWlYMF…
TRUALT Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE5kdTBoeHVoOEk5R1NCOGtsNUJSUHNxQmdRSnd4dFBnY3ZLX3RwT0RoNHFzdTVFNnVFVndrNndQTWtiaUkweWF4Z2FBT2dKVHhlOUpPeF81Mmxzd1UwZngwVE9wOE5nWGdhQVFNQWlreEFFQ0gyc2pyXw?oc=5" target="_blank">TRUAL…
TruAlt Bioenergy Ltd Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNNXNhemFMRkpDSm5ST1pCc3RfU3ZPZzBxeEZSWjN1Z3poTUdzSGZNN2ZER0tNdzJtRkNzaGZpQkx0YWF1M0p3MWVqT0hqS0ExQWNnVkxLRGt0Q3FycjE5MVdyUVQwc3pRLWlnekhjOF9GWU9tUVg2OGY0ZnJUSWh3TDBmQlVEbEgySFVDWA…
TruAlt Bioenergy's (NSE:TRUALT) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxQbk9adFFDMDhwQ1QxVWNsRzNvNEswa2hCM2dzdEVrMllyTFc4RnRqU0RHelJScGttdDR0RThVSE8xaXpST1dqR1otNWZqYWlDVUlOY1prNnd3Q2oxdjFCRnNYaUxGbHRjWjlVN0lQcXdzY2FpaW9sQTh1UGxReW5aY3k2djNTNlJhbTlPaj…
TruAlt Bioenergy AGM passes most resolutions; ED commission vote fails - scanx.trade
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNdXlfekdDYlRoSjg5R2ZlanptYm1JekZTYThWU3Fvc3hIX3Y3dldFM2hza1JVUnBmNUpfSXpZNVNYM19sVndzSngwenREYTN2azRLU09NaTJMLUJMdFY2Nmd0aU9PMFdCaUhFVWlsMXkxaDd0elY2YjBJUzl6clZwZ2UwYVpZMGY3VE5JOD…
Stock Stories: How Trualt Bioenergy is Fueling India’s Green Energy Ambitions - MarketSmith India
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNWHlrWmtpM21CalVxYlh6MW94OUI5ZUctQzlLVWk5YzNaRjVvaklyMmxHbUlaYm10czd2QkdXbnk4emh4X3g2c3U4NEhoVF9MNlN2SDlkNVdNTFhyRldOMTZVYmZyXzY2ODJFaS03NTZUTVNSUGF6Qk5YUXVRYmdieEV1OFo2Vll5N2x2UH…
TRUALT — Frequently Asked Questions
What is the current share price of TRUALT BIOENERGY LIMITED (TRUALT)?
As of 2026-09-08 04:53 IST, TRUALT BIOENERGY LIMITED (TRUALT) trades at ₹425.25 on NSE. Its 52-week range is ₹319.65 to ₹531.95.
What is the market capitalisation of TRUALT?
TRUALT BIOENERGY LIMITED (TRUALT) has a market capitalisation of ₹3,646.63 Cr on NSE.
What is the P/E ratio of TRUALT?
TRUALT trades at a trailing price-to-earnings (P/E) ratio of 34.57. The industry average P/E is 19.52. Its price-to-book (P/B) ratio is 2.69.
What is the return on equity (ROE) of TRUALT?
TRUALT has a return on equity (ROE) of 6.37%. Its return on capital employed (ROCE) is 10.77%.
Is TRUALT a good stock to buy?
This page provides a data-driven analysis of TRUALT BIOENERGY LIMITED (TRUALT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.